MetLife (NYSE:MET – Get Free Report) had its price target raised by analysts at Barclays from $90.00 to $96.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the financial services provider’s stock. Barclays‘s price target would indicate a potential upside of 15.69% from the stock’s current price.
Other research analysts also recently issued research reports about the company. Piper Sandler boosted their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. StockNews.com raised MetLife from a “hold” rating to a “buy” rating in a research report on Wednesday, January 1st. Wells Fargo & Company raised their target price on shares of MetLife from $92.00 to $93.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Jefferies Financial Group upped their target price on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Finally, TD Cowen upped their price target on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Fourteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $89.08.
Read Our Latest Research Report on MET
MetLife Price Performance
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the stock. Zurich Insurance Group Ltd FI acquired a new stake in shares of MetLife in the 3rd quarter valued at approximately $91,771,000. Dimensional Fund Advisors LP lifted its holdings in MetLife by 22.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock worth $378,799,000 after purchasing an additional 988,666 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its position in MetLife by 79.1% during the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock worth $142,378,000 after buying an additional 762,291 shares during the period. Jacobs Levy Equity Management Inc. increased its position in MetLife by 256.6% during the third quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider’s stock worth $78,209,000 after acquiring an additional 682,333 shares during the period. Finally, Nordea Investment Management AB raised its holdings in MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after acquiring an additional 608,224 shares in the last quarter. Institutional investors own 94.99% of the company’s stock.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Where Do I Find 52-Week Highs and Lows?
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Industrial Products Stocks Investing
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Stock Market Sectors: What Are They and How Many Are There?
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.